MARDIA SAMYOUNG CAPILLARY TUBES COMPANY LIMITED — Audited financial results for the quarter and year ended 31st March, 2026 (Quarter ended March 31, 2026; Quarter ended December 31, 2025; Quarter ended March 31, 2025; Year to date figures for the March 31, 2026 and March 31, 2025)
| Sr No | Particulars | Quarter ended March 31, 2026 (Audited) |
Quarter ended December 31, 2025 (Un-Audited) |
Quarter ended March 31, 2025 (Audited) |
Year to date figures for the March 31, 2026 (Audited) |
Year to date figures for the March 31, 2025 (Audited) |
|---|---|---|---|---|---|---|
| 1 | Revenue From Operations | |||||
| (a) Revenue from Operations | 6111.74 | 1234.50 | 0.00 | 7387.12 | 0.00 | |
| (b) Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 276.32 | |
| Total Income (Net) | 6111.74 | 1234.50 | 0.00 | 7387.12 | 276.32 | |
| 2 | Expenses | |||||
| a. Cost of Materials Consumed | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| b. Purchases of Stock-in-trade | 6363.42 | 1091.98 | 0.00 | 7490.29 | 0.00 | |
| c. Changes in inventories of Stock-in-Trade | (477.06) | (105.88) | 0.00 | (582.94) | 0.00 | |
| d. Employee benefits expenses | 21.69 | 2.01 | 1.36 | 26.29 | 6.52 | |
| e. Finance Cost | 0.05 | 0.00 | 0.00 | 0.05 | 0.00 | |
| f. Depreciation and Amortization Expenses | 0.02 | 0.03 | 0.00 | 0.05 | 0.00 | |
| g. Other Expenses | 23.16 | 56.98 | 4.03 | 104.71 | 149.85 | |
| Total Expenses | 5931.27 | 1045.12 | 5.39 | 7038.45 | 156.37 | |
| 3 | Profit/(Loss) before Exceptional and Extraordinary items and tax (1-2) | 180.47 | 189.38 | (5.39) | 348.67 | 119.95 |
| 4 | Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 5 | Profit/(Loss) before Extraordinary items and tax (3-4) | 180.47 | 189.38 | (5.39) | 348.67 | 119.95 |
| 6 | Extraordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 7 | Profit Before Tax (5-6) | 180.47 | 189.38 | (5.39) | 348.67 | 119.95 |
| 8 | Tax Expenses | |||||
| (a) Current Tax | 60.11 | 43.73 | 0.00 | 103.84 | 0.00 | |
| (b) Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| (c) Tax of Earlier Years | 5.65 | 16.58 | 0.00 | 22.23 | 0.00 | |
| Total Tax Expenses | 65.76 | 60.32 | 0.00 | 126.07 | 0.00 | |
| 9 | Net Profit/(Loss) for the period from continuing Operations (7-8) | 114.72 | 129.06 | (5.39) | 222.60 | 119.95 |
| 10 | Profit (Loss) from Discontinuing operations before Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 11 | Tax Expenses of Discontinuing Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 12 | Net Profit/(Loss) from Discontinuing operations after Tax (10-11) | 114.72 | 129.06 | (5.39) | 222.60 | 119.95 |
| 13 | Share of Profit (Loss) of associates and Joint Ventures accounted for using equity method | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 14 | Net Profit (Loss) for the period (12+13) | 114.72 | 129.06 | (5.39) | 222.60 | 119.95 |
| 15 | Other comprehensive income, net of income tax | |||||
| a) i) Amount of item that will not be reclassified to profit or loss | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ii) Income tax relating to items that will not be reclassified to profit or loss | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| b) i) item that will be reclassified to profit or loss | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ii) income tax relating to items that will be reclassified to profit or loss | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total other comprehensive income, net of income tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 16 | Total Comprehensive income for the period | 114.72 | 129.06 | (5.39) | 222.60 | 119.95 |
| 17 | Details of equity share capital | |||||
| Paid-up Equity Share Capital | 6774.64 | 696.14 | 696.14 | 6774.64 | 696.14 | |
| Face Value of Equity Share Capital | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |
| 18 | Details of debt securities | |||||
| Paid -Up Debt capital | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Face value of debt Securities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 19 | Reserve excluding revaluation reserves as per balance sheet of previous accounting year | 0.00 | 0.00 | 0.00 | 0.00 | (132.95) |
| 20 | Debenture Redemption reserve | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 21 | Earning per Share | |||||
| i | Earning per Share for Continuing Operations | |||||
| Basic Earning (Loss) per share from Continuing operations | 0.17 | 1.85 | (0.08) | 0.33 | 1.72 | |
| Diluted Earning (Loss) per share from Continuing operations | 0.17 | 1.85 | (0.08) | 0.33 | 1.72 | |
| ii | Earning per Share for discontinuing Operations | |||||
| Basic Earning (Loss) per share from discontinuing operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Diluted Earning (Loss) per share from discontinuing operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| iii | Earnings per Equity Share | |||||
| Basic Earning (Loss) per share from Continuing and discontinuing operations | 0.17 | 1.85 | (0.08) | 0.33 | 1.72 | |
| Diluted Earning (Loss) per share from Continuing and discontinuing operations | 0.17 | 1.85 | (0.08) | 0.33 | 1.72 |
| Particulars | Audited AS AT 31.03.2026 | Audited AS AT 31.03.2025 |
|---|---|---|
| 1 Assets | ||
| A Non-Current Assets | ||
| (a) Property, Plant and Equipment | 0.60 | – |
| (b) Capital work-in-progress | – | – |
| (c) Investment Property | – | – |
| (d) Goodwill | – | – |
| (e) Other Intangible assets | – | – |
| (f) Intangible assets under development | – | – |
| (g) Biological Assets other than bearer plants | – | – |
| (h) Financial Assets | ||
| – (i) Investments | – | – |
| – (ii) Trade receivables | – | – |
| – (iii) Loans | 23.79 | 2.41 |
| – (iv) Others (to be specified) | – | – |
| (i) Deferred tax assets (net) | 321.20 | 321.20 |
| (j) Other non-current assets | – | – |
| Total (A) | 345.59 | 323.61 |
| B Current assets | ||
| (a) Inventories | 582.94 | – |
| (b) Financial Assets | ||
| – (i) Investments | 0.04 | 0.01 |
| – (ii) Trade receivables | 5,571.55 | – |
| – (iii) Cash and cash equivalents | 12.57 | 0.71 |
| – (iv) Bank balances other than (iii) above | – | – |
| – (v) Loans | 2,975.00 | 220.29 |
| – (vi) Others (to be specified) | – | – |
| (c) Current Tax Assets (Net) | – | – |
| (d) Other current assets | 37.52 | 30.77 |
| Total (B) | 9,179.62 | 251.78 |
| Total Assets (A+B) | 9,525.21 | 575.39 |
| 2 EQUITY AND LIABILITIES | ||
| A EQUITY | ||
| (a) Equity Share capital | 6,774.64 | 696.14 |
| (b) Share Application Money Received | 395.38 | – |
| (c) Other Equity | 2,217.13 | (132.95) |
| Total (A) | 9,387.15 | 563.20 |
| B LIABILITIES | ||
| B1 Non-current liabilities | ||
| (a) Financial Liabilities | ||
| – (i) Borrowings | 0.23 | – |
| – (ii) Trade payables | – | – |
| – (iii) Other financial liabilities | – | – |
| (b) Provisions | – | – |
| (c) Deferred tax liabilities (Net) | – | – |
| (d) Other non-current liabilities | – | – |
| Total (B1) | 0.23 | – |
| B2 Current liabilities | ||
| (a) Financial Liabilities | ||
| – (i) Borrowings | – | – |
| – (ii) Trade payables | – | – |
| – (a) total outstanding dues of micro enterprises and small enterprises | – | – |
| – (b) total outstanding dues of creditors other than micro enterprises and small enterprises | 26.77 | 11.62 |
| – (iii) Other financial liabilities | – | – |
| (b) Other current liabilities | 6.72 | – |
| (c) Provisions | 104.34 | 0.57 |
| (d) Current Tax Liabilities (Net) | – | – |
| Total (B2) | 137.83 | 12.19 |
| Total Equity and Liabilities (A+B1+B2) | 9,525.21 | 575.39 |
| Particulars | Year Ended 31st March, 2026 | Year Ended 31st March, 2025 |
|---|---|---|
| (A) CASH FLOW FROM OPERATING ACTIVITIES | ||
| 1. Net Profit Before Tax | 348.67 | (156.38) |
| 2. Adjustments for: | ||
| a) Depreciation | 0.05 | 0.00 |
| b) Interest Income | 0.00 | 0.00 |
| c) Gain or Loss from Sale of Fixed Assets | – | 276.33 |
| Operating Profit before Working Capital change (1+2) | 348.72 | 119.95 |
| 3. Adjustments for Working Capital Changes: | ||
| Decrease/(Increase) in Receivables | (5,571.55) | 0.00 |
| Decrease/(Increase) in Inventories | (582.94) | 74.29 |
| Increase/(Decrease) in Borrowings | – | (83.07) |
| Decrease/(Increase) in Advances | (2,754.71) | (220.29) |
| Decrease/(Increase) in Other Current Assets | (6.75) | (0.48) |
| Increase/(Decrease) in Provisions | 103.77 | 0.00 |
| Increase/(Decrease) in Payables | 15.15 | (73.77) |